MetLife Investment Management’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $142K | Sell |
1,858
-20
| -1% | -$1.44K | ﹤0.01% | 2378 |
|
|
2025
Q4 | $120K | Sell |
1,878
-26,608
| -93% | -$1.64M | ﹤0.01% | 2525 |
|
|
2025
Q3 | $1.8M | Sell |
28,486
-919
| -3% | -$64.1K | 0.01% | 1137 |
|
|
2025
Q2 | $2.2M | Sell |
29,405
-506
| -2% | -$39.8K | 0.01% | 952 |
|
|
2025
Q1 | $2.64M | Sell |
29,911
-783
| -3% | -$73.9K | 0.01% | 909 |
|
|
2024
Q4 | $2.8M | Buy |
30,694
+301
| +1% | +$30.9K | 0.02% | 875 |
|
|
2024
Q3 | $3.4M | Sell |
30,393
-969
| -3% | -$96.9K | 0.02% | 744 |
|
|
2024
Q2 | $3.07M | Buy |
31,362
+3,876
| +14% | +$385K | 0.02% | 767 |
|
|
2024
Q1 | $2.75M | Sell |
27,486
-1,292
| -4% | -$114K | 0.02% | 814 |
|
|
2023
Q4 | $2.58M | Sell |
28,778
-542
| -2% | -$43.2K | 0.02% | 838 |
|
|
2023
Q3 | $2.25M | Sell |
29,320
-907
| -3% | -$75.3K | 0.02% | 851 |
|
|
2023
Q2 | $2.53M | Sell |
30,227
-445
| -1% | -$36.2K | 0.02% | 839 |
|
|
2023
Q1 | $2.59M | Sell |
30,672
-653
| -2% | -$56.1K | 0.02% | 816 |
|
|
2022
Q4 | $2.55M | Sell |
31,325
-1,260
| -4% | -$102K | 0.02% | 796 |
|
|
2022
Q3 | $2.32M | Sell |
32,585
-2,123
| -6% | -$191K | 0.02% | 816 |
|
|
2022
Q2 | $3.12M | Sell |
34,708
-488
| -1% | -$50.5K | 0.02% | 701 |
|
|
2022
Q1 | $3.94M | Buy |
35,196
+5,494
| +18% | +$644K | 0.03% | 671 |
|
|
2021
Q4 | $3.59M | Sell |
29,702
-965
| -3% | -$107K | 0.03% | 575 |
|
|
2021
Q3 | $3.09M | Sell |
30,667
-983
| -3% | -$108K | 0.03% | 622 |
|
|
2021
Q2 | $3.7M | Sell |
31,650
-725
| -2% | -$87K | 0.03% | 552 |
|
|
2021
Q1 | $3.57M | Sell |
32,375
-523
| -2% | -$56.8K | 0.03% | 580 |
|
|
2020
Q4 | $3.3M | Sell |
32,898
-1,419
| -4% | -$132K | 0.03% | 574 |
|
|
2020
Q3 | $2.68M | Sell |
34,317
-1,224
| -3% | -$92.3K | 0.03% | 595 |
|
|
2020
Q2 | $2.48M | Buy |
35,541
+491
| +1% | +$30.9K | 0.03% | 623 |
|
|
2020
Q1 | $1.63M | Sell |
35,050
-1,072
| -3% | -$68.8K | 0.02% | 688 |
|
|
2019
Q4 | $2.86M | Sell |
36,122
-1,159
| -3% | -$89.1K | 0.03% | 652 |
|
|
2019
Q3 | $2.75M | Sell |
37,281
-916
| -2% | -$65.7K | 0.03% | 646 |
|
|
2019
Q2 | $2.97M | Sell |
38,197
-1,535
| -4% | -$117K | 0.03% | 622 |
|
|
2019
Q1 | $3.01M | Sell |
39,732
-318
| -0.8% | -$25.3K | 0.03% | 614 |
|
|
2018
Q4 | $2.93M | Sell |
40,050
-1,048
| -3% | -$83.6K | 0.04% | 558 |
|
|
2018
Q3 | $3.93M | Sell |
41,098
-927
| -2% | -$91.9K | 0.04% | 499 |
|
|
2018
Q2 | $4.2M | Sell |
42,025
-999
| -2% | -$105K | 0.05% | 389 |
|
|
2018
Q1 | $4.54M | Sell |
43,024
-1,448
| -3% | -$146K | 0.05% | 365 |
|
|
2017
Q4 | $4.12M | Buy |
+44,472
| New | +$4.04M | 0.05% | 447 |
|
Other funds holding EMN
VPM
VCM
MetLife Investment Management's EMN Position: Q1 2026 in Review
MetLife Investment Management reduced its Eastman Chemical (EMN) stake by 1.1% in Q1 2026, selling an estimated $1.44K and leaving 1,858 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2378.
MetLife Investment Management first reported a position in EMN in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.54M in Q1 2018. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- MetLife Investment Management held 1,858 shares of Eastman Chemical worth $142K as of Q1 2026.
- MetLife Investment Management sold 20 Eastman Chemical shares in Q1 2026, an estimated $1.44K.
- Eastman Chemical made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2378 holding.
- MetLife Investment Management first reported a position in Eastman Chemical in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Eastman Chemical position peaked at $4.54M in Q1 2018.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.